Spirometry in atrial fibrillation: what's the catch?

Expert review of respiratory medicine Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI:10.1080/17476348.2023.2279236
Anne E Ioannides, Upasana Tayal, Jennifer K Quint
{"title":"Spirometry in atrial fibrillation: what's the catch?","authors":"Anne E Ioannides, Upasana Tayal, Jennifer K Quint","doi":"10.1080/17476348.2023.2279236","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>People with COPD rarely have COPD alone, and the commonest co-morbidities occurring with COPD are cardiovascular. Whilst multiple studies have explored the association between major cardiovascular events and COPD, less attention has been paid to arrhythmias, specifically atrial fibrillation (AF). AF and COPD frequently occur together, posing challenges in diagnosis and management. In this review, we describe the relationship between AF and COPD epidemiologically and physiologically, demonstrating the role of spirometry as a diagnostic and disease management tool.</p><p><strong>Areas covered: </strong>We provide epidemiological evidence that COPD and AF are independent risk factors for one another, that either disease is highly prevalent amongst people with the other, and that they have shared risk factors; all of which contribute to adverse prognostic. We elucidated common pathophysiological mechanisms implicated in AF-COPD. We ultimately present the epidemiological and physiological evidence with a view to highlight specific areas where we feel spirometry is of value in the management of AF-COPD.</p><p><strong>Expert opinion: </strong>AF and COPD commonly co-occur, there is often diagnostic delay, increased risk of reduced cardioversion success, and missed opportunity to intervene to reduce stroke risk. Greater awareness and timelier diagnosis and guideline directed management may improve outcomes for people with both diseases.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17476348.2023.2279236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: People with COPD rarely have COPD alone, and the commonest co-morbidities occurring with COPD are cardiovascular. Whilst multiple studies have explored the association between major cardiovascular events and COPD, less attention has been paid to arrhythmias, specifically atrial fibrillation (AF). AF and COPD frequently occur together, posing challenges in diagnosis and management. In this review, we describe the relationship between AF and COPD epidemiologically and physiologically, demonstrating the role of spirometry as a diagnostic and disease management tool.

Areas covered: We provide epidemiological evidence that COPD and AF are independent risk factors for one another, that either disease is highly prevalent amongst people with the other, and that they have shared risk factors; all of which contribute to adverse prognostic. We elucidated common pathophysiological mechanisms implicated in AF-COPD. We ultimately present the epidemiological and physiological evidence with a view to highlight specific areas where we feel spirometry is of value in the management of AF-COPD.

Expert opinion: AF and COPD commonly co-occur, there is often diagnostic delay, increased risk of reduced cardioversion success, and missed opportunity to intervene to reduce stroke risk. Greater awareness and timelier diagnosis and guideline directed management may improve outcomes for people with both diseases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心房颤动的肺活量测定:有什么问题?
引言:COPD患者很少单独患有COPD,与COPD发生的最常见的合并症是心血管疾病。虽然多项研究探讨了主要心血管事件与COPD之间的关系,但对心律失常,特别是心房颤动(AF)的关注较少。房颤和慢性阻塞性肺病经常同时发生,这给诊断和管理带来了挑战。在这篇综述中,我们从流行病学和生理学角度描述了房颤与COPD之间的关系,证明了肺活量测定作为诊断和疾病管理工具的作用。涵盖的领域:我们提供了流行病学证据,证明COPD和AF是彼此独立的风险因素,其中一种疾病在人群中高度流行,并且它们有共同的风险因素;所有这些都会导致不良预后。我们阐明了AF-COPD的常见病理生理机制。我们最终提出流行病学和生理学证据,以强调我们认为肺活量测定在AF-COPD管理中有价值的特定领域。专家意见:AF和COPD通常同时发生,通常存在诊断延迟,心脏复律成功率降低的风险增加,并错过了干预以降低中风风险的机会。提高认识、及时诊断和指导方针指导的管理可能会改善这两种疾病患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Awareness of COPD in low- and middle-income countries and implications for treatment. The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators. New methods to detect bacterial or viral infections in patients with chronic obstructive pulmonary disease. It is high time to discard a cut-off of 0.70 in the diagnosis of COPD. Imagining the severe asthma decision trees of the future.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1